KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcosa (ACA) Cash & Equivalents (2017 - 2025)

Historic Cash & Equivalents for Arcosa (ACA) over the last 9 years, with Q3 2025 value amounting to $220.0 million.

  • Arcosa's Cash & Equivalents fell 7093.02% to $220.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $220.0 million, marking a year-over-year decrease of 7093.02%. This contributed to the annual value of $187.3 million for FY2024, which is 7872.14% up from last year.
  • According to the latest figures from Q3 2025, Arcosa's Cash & Equivalents is $220.0 million, which was down 7093.02% from $189.7 million recorded in Q2 2025.
  • Over the past 5 years, Arcosa's Cash & Equivalents peaked at $756.8 million during Q3 2024, and registered a low of $66.1 million during Q3 2021.
  • For the 5-year period, Arcosa's Cash & Equivalents averaged around $166.8 million, with its median value being $149.2 million (2023).
  • Per our database at Business Quant, Arcosa's Cash & Equivalents soared by 38731.49% in 2024 and then plummeted by 7093.02% in 2025.
  • Arcosa's Cash & Equivalents (Quarter) stood at $72.9 million in 2021, then soared by 120.03% to $160.4 million in 2022, then plummeted by 34.66% to $104.8 million in 2023, then skyrocketed by 78.72% to $187.3 million in 2024, then grew by 17.46% to $220.0 million in 2025.
  • Its Cash & Equivalents stands at $220.0 million for Q3 2025, versus $189.7 million for Q2 2025 and $167.9 million for Q1 2025.